Found 18 matching trials
GV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD)
PHASE3The objective of this study is to evaluate the safety and efficacy of GV100...
Location
Multiple Locations
Evaluate the Efficacy and Safety of GV1001 in Patients With Benign Prostatic Hyperplasia (BPH)
PHASE3The current study is being conducted by the Sponsor to evaluate the efficac...
Location
Hanyang University Guri Hospital
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
PHASE2This clinical study is designed as a multi-center, randomized, double-blind...
Location
Hanyang University Guri Hospital
Immunochemoradiotherapy in Patients With Pancreatic Cancer
PHASE1This study will add an immunotherapy component to chemotherapy and radiatio...
Location
Providence Health & Services
GV 1001 Immunotherapy in Patients With Non-small Cell Lung Cancer (NSCLC)
NATo examine the safety and efficacy of telomerase peptide vaccination ( stim...
Location
Rikshospitalet - Radiumhospitalet HF
GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer
PHASE3To investigate the efficacy of GV1001 in sequential combination with gemcit...
Location
University of South Alabama Mitchell Cancer Institute
Study of the Telomerase Vaccine GV1001 to Treat Patients With Inoperable Stage III Non-small Cell Lung Cancer
PHASE3The purpose of this study is to evaluate survival in inoperable stage III N...
Location
Multiple Locations
Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
PHASE3RATIONALE: Drugs used in chemotherapy, such as gemcitabine and capecitabine...
Location
North Devon District Hospital
A Study, Combination, Immunologic Study of LTX-315 as Adjunct to GV1001 in Patients Following Curative Surgery for Carcinoma
PHASE1This study involves testing of the medicine LTX-315 combined with a cancer ...
Location
University Hospital North-Norway
Administration of GV1001 for the Treatment of Progressive Supranuclear Palsy Who Completed Study GV1001-PSP-CL2-011
PHASE2The study will be conducted by the Sponsor to evaluate Twelve-months Long-T...
Location
Seoul National University Bundang Hospital